Market News / Story
SRX Global Inc. (SRXH) To Acquire CERo Therapeutics Via SPV
·
SRX Global entered a definitive agreement to acquire CERo Therapeutics via SPV CERO 1236, which will raise capital at the subsidiary level and avoid diluting existing SRX shareholders. The deal is expected to accelerate CER-1236 development for hematologic malignancies. Material Details #DetailAI Analyst View1Definitive deal to acquire CERoChange-of-control event can re-rate SRXH on oncology optionality and platform shift.2SPV to raise capital at subsidiarySignals no…